Corporate Presentation
| Date | Documents | PDF Download |
|---|---|---|
| June 8, 2026 | Karyopharm Endometrial Cancer Treatment Landscape and Commercial Opportunity | |
| June 2, 2026 | Karyopharm Phase 3 SENTRY Results & Myelofibrosis Commercial Opportunity | |
| May 18, 2026 | Karyopharm Corporate Presentation | |
| May 14, 2026 | Karyopharm 1Q26 Earnings Presentation |
Events & Presentations
Browse the calendar to view Investor related events and announcements. Webcasts and presentations that have been archived are available by viewing historical event details.
These presentations may contain forward-looking statements that are based on the expectations and beliefs of Karyopharm at the time of the presentation. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, risks and uncertainties. Please refer to our SEC filings, which can be found at https://investors.karyopharm.com/sec-filings, including the “Risk Factors” sections of these filings, for more information.
- Upcoming Events
- Past Events
